Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate response prediction in children with ADHD using DAT1/COMT, EEG, and fMRI markers
NL-OMON41454Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University Medical Center Utrecht. Primary endpoints: Stop-associated ERP measures at baseline, Stop-associated fMRI measures at baseline and 1 more. Started Apr 2013; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON41454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41454.